How many insider trades does FilingIQ track for VTRS?

FilingIQ tracks 730 Form 4 insider transactions for VTRS (Viatris Inc), covering filings from Nov 13, 2020 onwards. 165 of those were filed in the last 90 days.

Are VTRS insiders net buyers or net sellers?

Across the full Form 4 history for VTRS, 20 transactions (3%) were open-market purchases and 31 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does VTRS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is VTRS in?

Viatris Inc (VTRS) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $16.77B.

VTRS insider trading

NasdaqGS Healthcare

Viatris Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

730

Last 90 days

165

Buys / sells

3% / 4%

Market cap

$16.77B

About Viatris Inc

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Company website: www.viatris.com

VTRS insider activity at a glance

FilingIQ has scored 730 insider transactions for VTRS since Nov 13, 2020. The most recent filing in our index is dated Apr 15, 2026.

Across the full history, 20 open-market purchases and 31 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on VTRS insider trades is 56.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live VTRS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

HOLX 151

HOLOGIC INC

Top insiders trading VTRS

DAMELIO FRANK A

12 trades · score 72.0

13F funds holding VTRS

DAVIS SELECTED ADVISERS

$686.52M · 3.6% of AUM

Rubric Capital Management LP

$130.65M · 4.9% of AUM

EASTERLY INVESTMENT PARTNERS LLC

$29.34M · 2.6% of AUM

Frequently asked

How many insider trades does FilingIQ track for VTRS?: FilingIQ tracks 730 Form 4 insider transactions for VTRS (Viatris Inc), covering filings from Nov 13, 2020 onwards. 165 of those were filed in the last 90 days.
Are VTRS insiders net buyers or net sellers?: Across the full Form 4 history for VTRS, 20 transactions (3%) were open-market purchases and 31 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VTRS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VTRS in?: Viatris Inc (VTRS) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $16.77B.

Methodology & sources

Every VTRS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.